PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases.
CEO and founder Daphne Zohar joined Proactive’s Stephen Gunnion to discuss the company’s pipeline of therapeutics and therapeutic candidates, its strategy, and its investment case. Zohar also touched on news just out of the acquisition of the remaining 22% of shares outstanding in its founded entity, Alivio Therapeutics.